📰 Edwards Lifescience News
Edwards Lifescience News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Edwards Lifescience. Real-time updates on events, politics, business and more.
June 5, 2024
Becton, Dickinson and Company (BDX: NYSE) acquires Edwards Lifesciences (EW: NYSE) Critical Care product group for $4.2 billion in cash.
June 4, 2024
E*Trade Considers Kicking Meme-Stock Leader Keith Gill Off Platform Morgan Stanleys trading platform discusses concerns about possible manipulation in GameStop. Spotify Shares Jump on... -June 03, 2024 at 09:15 pm EDT - MarketScreener
June 3, 2024
E*Trade Considers Kicking Meme-Stock Leader Keith Gill Off Platform Morgan Stanleys trading platform discusses concerns about possible manipulation in GameStop. Spotify Shares Jump on... -June 03, 2024 at 05:16 pm EDT - MarketScreener
May 20, 2024
The APAC Transcatheter Aortic-Valve Replacement (TAVR) market is projected to grow significantly, with the market size expected to reach approximately USD 3.8 billion by 2033, up from USD 1.2 billion in 2023, reflecting a compound annual growth rate (CAGR) of 12.2% during the forecast period from 2024 to 2033. This...
May 1, 2024
Edwards Lifesciences Co. (NYSE:EW – Free Report) – Research analysts at Leerink Partnrs raised their Q3 2024 EPS estimates for shares of Edwards Lifesciences in a research report issued to clients and investors on Friday, April 26th. Leerink Partnrs analyst M. Kratky now expects that the medical research company will earn $0.71 per share for […]
April 25, 2024
Insights into Edwards Lifesciences' Financial Performance and Strategic Highlights
April 23, 2024
Born of a spin-off from Baxter International in the 2000s, Edwards Lifesciences specializes in medical devices, and more specifically in the cardiovascular field. Despite a rather mixed stock market...
February 8, 2024
Edwards Lifesciences Co. (NYSE:EW – Free Report) – Equities research analysts at William Blair lowered their Q1 2024 EPS estimates for Edwards Lifesciences in a report issued on Wednesday, February 7th. William Blair analyst M. Kaczor now forecasts that the medical research company will post earnings of $0.64 per share for the quarter, down from […]
February 8, 2024
Edwards Lifesciences Co. (NYSE:EW – Free Report) – Leerink Partnrs decreased their Q1 2024 earnings estimates for Edwards Lifesciences in a research note issued to investors on Wednesday, February 7th. Leerink Partnrs analyst M. Kratky now anticipates that the medical research company will earn $0.65 per share for the quarter, down from their previous forecast […]
February 6, 2024
Strong Sales Growth and Strategic Advances Position EW for Future Expansion